Patents by Inventor Zhanling Wang

Zhanling Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230089901
    Abstract: One or more purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed.
    Type: Application
    Filed: September 23, 2022
    Publication date: March 23, 2023
    Inventors: Alla DANILKOVICH, Robert E. NEWMAN, Samson TOM, Christopher TON, Zhanling WANG, Randell G. YOUNG
  • Publication number: 20200197444
    Abstract: One or more purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed.
    Type: Application
    Filed: November 25, 2019
    Publication date: June 25, 2020
    Inventors: Alla Danilkovich, Robert E. Newman, Samson Tom, Christopher Ton, Zhanling Wang, Randell Young
  • Publication number: 20180008642
    Abstract: One or more purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed.
    Type: Application
    Filed: May 23, 2017
    Publication date: January 11, 2018
    Inventors: Alla Danilkovich, Robert E. Newman, JR., Samson Tom, Christopher Ton, Zhanling Wang, Randell G. Young
  • Publication number: 20140105872
    Abstract: One or more purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed.
    Type: Application
    Filed: December 16, 2013
    Publication date: April 17, 2014
    Inventors: Alla Danilkovich, Robert E. Newman, JR., Samson Tom, Christopher Ton, Zhanling Wang, Randell G. Young
  • Patent number: 8637004
    Abstract: One or more purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed.
    Type: Grant
    Filed: August 14, 2009
    Date of Patent: January 28, 2014
    Assignee: Mesoblast International Sarl
    Inventors: Alla Danilkovich, Robert E. Newman, Jr., Samson Tom, Christopher Ton, Zhanling Wang, Randell G. Young
  • Publication number: 20100068191
    Abstract: One or more purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed.
    Type: Application
    Filed: August 14, 2009
    Publication date: March 18, 2010
    Inventors: Alla Danilkovich, Robert E. Newman, JR., Samson Tom, Christopher Ton, Zhanling Wang, Randell G. Young